Cargando…

BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers

Here, BTG1 overexpression inhibited proliferation, induced differentiation, autophagy, and apoptosis in colorectal cancer cells (p(2) arrest might be related to Cyclin B1 and Cdc25B hypoexpression in HCT-15 transfectants, while G(1) arrest in HCT-116 transfectants overexpressing p21 and p27. BTG1 ov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Shuang, Chen, Shu-rui, Yang, Xue-feng, Shen, Dao-fu, Takano, Yasuo, Su, Rong-jian, Zheng, Hua-chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352338/ https://www.ncbi.nlm.nih.gov/pubmed/27447746 http://dx.doi.org/10.18632/oncotarget.10649

Ejemplares similares

The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy
por: Gou, Wen-feng, et al.
Publicado: (2015)

BTG1 Overexpression Might Promote Invasion and Metastasis of Colorectal Cancer via Decreasing Adhesion and Inducing Epithelial–Mesenchymal Transition
por: Zhao, Shuang, et al.
Publicado: (2020)

Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma
por: Deng, Boya, et al.
Publicado: (2013)

BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy
por: Zheng, Hua-chuan, et al.
Publicado: (2015)

BTG1 Expression Correlates with the Pathogenesis and Progression of Ovarian Carcinomas
por: Zhao, Yang, et al.
Publicado: (2013)

Beclin 1 Expression is Closely Linked to Colorectal Carcinogenesis and Distant Metastasis of Colorectal Carcinoma
por: Zhang, Mei-Ying, et al.
Publicado: (2014)

The suppressing effects of BTG3 expression on aggressive behaviors and phenotypes of colorectal cancer: An in vitro and vivo study
por: Zheng, Hua-Chuan, et al.
Publicado: (2017)

Downregulated inhibitor of growth 3 (ING3) expression during colorectal carcinogenesis
por: Gou, Wen-feng, et al.
Publicado: (2014)

The roles of BTG1 mRNA expression in cancers: A bioinformatics analysis
por: Zheng, Hua-chuan, et al.
Publicado: (2022)

Emerging role of antiproliferative protein BTG1 and BTG2
por: Kim, Sang Hyeon, et al.
Publicado: (2022)

Tumor suppressors BTG1 and BTG2: Beyond growth control
por: Yuniati, Laurensia, et al.
Publicado: (2018)

The function of BTG3 in colorectal cancer cells and its possible signaling pathway
por: Lv, Chi, et al.
Publicado: (2017)

Targeted Deletion of Btg1 and Btg2 Results in Homeotic Transformation of the Axial Skeleton
por: Tijchon, Esther, et al.
Publicado: (2015)

The clinicopathological significances and related signal pathways of BTG3 mRNA expression in cancers: A bioinformatics analysis
por: Zheng, Hua-Chuan, et al.
Publicado: (2022)

Berberine might block colorectal carcinogenesis by inhibiting the regulation of B-cell function by Veillonella parvula
por: Qian, Yun, et al.
Publicado: (2023)

ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression
por: Gou, Wen-feng, et al.
Publicado: (2015)

Self-employed: 50 signs that you might be an entrepreneur
por: Comm, Joel, et al.
Publicado: (2017)

Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis
por: Li, Dao-Jiang, et al.
Publicado: (2018)

BTG Interacts with Retinoblastoma to Control Cell Fate in Dictyostelium
por: Conte, Daniele, et al.
Publicado: (2010)

Impact of AKT1 Polymorphism on DNA Damage, BTG2 Expression, and Risk of Colorectal Cancer Development
por: Zubair, Hina, et al.
Publicado: (2022)

Inhibition of TNFα-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2(/TIS21) via downregulating cytoplasmic nucleolin expression
por: Devanand, Preethi, et al.
Publicado: (2018)

The Suppressive Role and Aberrent Promoter Methylation of BTG3 in the Progression of Hepatocellular Carcinoma
por: Lv, Zhenbing, et al.
Publicado: (2013)

On the Use of Vinous Stimulants in Circumstances Which Might Seem to Forbid Their Employment
por: Law, William
Publicado: (1827)

A conserved motif in human BTG1 and BTG2 proteins mediates interaction with the poly(A) binding protein PABPC1 to stimulate mRNA deadenylation
por: Amine, Hamza, et al.
Publicado: (2021)

Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3‐Dependent Podocyte‐Mesenchymal Transition
por: Dan Hu, Qiong‐, et al.
Publicado: (2023)

Role of Btg2 in the Progression of a PDGF-Induced Oligodendroglioma Model
por: Appolloni, Irene, et al.
Publicado: (2012)

The extramural metastasis might be categorized in lymph node staging for colorectal cancer
por: Qiu, Hai-Bo, et al.
Publicado: (2011)

Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma
por: Xue, Kai, et al.
Publicado: (2021)

Benzodiazepine-Associated Carcinogenesis: Focus on Lorazepam-Associated Cancer Biomarker Changes in Overweight Individuals
por: Ku, Shih-Chieh, et al.
Publicado: (2018)

ING Genes Work as Tumor Suppressor Genes in the Carcinogenesis of Head and Neck Squamous Cell Carcinoma
por: Li, Xiaohan, et al.
Publicado: (2011)

Elevated BTG2 improves the radiosensitivity of non‐small cell lung cancer (NSCLC) through apoptosis
por: Zhu, Changchun, et al.
Publicado: (2022)

Evolution of Tumor Metabolism might Reflect Carcinogenesis as a Reverse Evolution process (Dismantling of Multicellularity)
por: Alfarouk, Khalid O., et al.
Publicado: (2011)

Biomarkers for Sepsis: What Is and What Might Be?
por: Biron, Bethany M., et al.
Publicado: (2015)

Beyond the genome (BTG) is a (PGDB) pathway genome database: HumanCyc
por: Trupp, Miles, et al.
Publicado: (2010)

ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma
por: Yanagida, Satoshi, et al.
Publicado: (2013)

BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma
por: Li, Yibing, et al.
Publicado: (2020)

BTG2 as a tumor target for the treatment of luminal A breast cancer
por: Wang, Runzhi, et al.
Publicado: (2022)

KDM3A, a Novel Blood-Based Biomarker in Colorectal Carcinogenesis
por: Polat, D., et al.
Publicado: (2023)

The relationship between pepsinogen C and gastric carcinogenesis: a transgene and population study
por: E., Ying, et al.
Publicado: (2023)

Overexpression of MEKK2 is associated with colorectal carcinogenesis
por: JIANG, LI, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8n6rsr63khdhieas3tf55kr807